Cancer feature: cnaPANCAN367

ADRM1 ANKRD60 APCDD1L ARFGAP1 ATP5E AURKA BCAS1 BHLHE23 BIRC7 BMP7 C20orf166 C20orf195 C20orf197 C20orf85 CABLES2 CASS4 CBLN4 CDH26 CDH4 CHRNA4 COL20A1 COL9A3 CSTF1 CTCFL CTSZ CYP24A1 DIDO1 DOK5 EDN3 EEF1A2 FAM209A FAM209B FAM210B FAM217B GATA5 GCNT7 GID8 GMEB2 GNAS HELZ2 HRH3 KCNQ2 LAMA5 LSM14B MC3R MRGBP MTG2 MTRNR2L3 NELFCD NKAIN4 NPEPL1 NTSR1 OGFR OSBPL2 PCK1 PFDN4 PHACTR3 PMEPA1 PPDPF PPP1R3D PPP4R1L PSMA7 PTK6 RAB22A RAE1 RBBP8NL RBM38 RP11-429E11.3 RP11-93B14.6 RPS21 RTFDC1 SLC17A9 SLCO4A1 SLMO2 SPO11 SRMS SS18L1 STX16 STX16-NPEPL1 SYCP2 TAF4 TCFL5 TFAP2C TSHZ2 TUBB1 VAPB YTHDF1 ZBP1 ZFP64 ZNF217 ZNF831

Known Driver Genes: GNAS

Copy number alternation: gain

Mirin

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).

Genomics of Drug Sensitivity in Cancer